Delivery Order SPE2DR25D2104-SPE2DR26F3TTS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,300.82 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Humira Pen 40 mg/0.8 mL. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, was issued on a non-competitive basis with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $48.4K delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency awarded a $15,729.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of HUMIRA (CF) Pen 80 mg/0.8 mls, a pharmaceutical product with a completion date of January 23, 2026. This award was made on a non-set-aside, competitive basis and represents a task order under a larger contracting vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 15, 2026, by the Defense Logistics Agency for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic medication used to treat inflammatory conditions. The contract is valued at $2,387.94 with a firm fixed-price structure and an ultimate completion date of January 16, 2026. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $6,204.34 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply relationships. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.94 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 80 mg/0.8 mls, a pharmaceutical product for treating autoimmune conditions. This competitive award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $7,659.60 to supply Humira Pen 40 mg/0.8 mL, with an ultimate completion date of November 10, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $13,143.30 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on January 14, 2026, with a completion date of January 15, 2026. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,989.76 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat inflammatory conditions. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, carries a firm fixed price and represents a non-competitive delivery order. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls on July 21, 2025, with a completion date of July 22, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TTSDelivery Order
The Defense Logistics Agency awarded a $1,591.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, with an ultimate completion date of January 16, 2026. The contract covers the delivery of HUMIRA (CF) Pen 80 mg/0.8 mL, a pharmaceutical product to be performed at the company's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's established capability to meet federal procurement requirements in the pharmaceutical supply chain. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031. The parent IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related commodities—to support military healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Pennsylvania, plays a critical role in supplying essential medications to Defense Health Agency facilities, the U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/14/26 |